Margaret McLoughlin
Direttore/Membro del Consiglio presso QUINCE THERAPEUTICS, INC.
Patrimonio netto: 6 640 $ in data 31/05/2024
Posizioni attive di Margaret McLoughlin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| QUINCE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/12/2015 | - |
| Independent Dir/Board Member | 01/12/2015 | - |
Storia della carriera di Margaret McLoughlin
Precedenti posizioni note di Margaret McLoughlin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2014 | 01/05/2019 |
| 4D MOLECULAR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - | 20/03/2019 |
| Yale University | Corporate Officer/Principal | 01/01/1991 | - |
| BIOATLA, INC. | Direttore/Membro del Consiglio | - | - |
Herophilus, Inc.
 Herophilus, Inc. Packaged SoftwareTechnology Services Herophilus, Inc. operates as neurotherapeutics company. It employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. The firm combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. The company was founded by Frederic J. Kerrest, Sean Escola and Saul Kato and is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | - | - |
Adapsyn Bioscience, Inc.
 Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Adapsyn Bioscience, Inc. operates as a biotechnology company focussed on the discovery and development of novel medicines. The company was founded by Nathan Magarvey and is headquartered in Hamilton, Canada. | Direttore/Membro del Consiglio | - | - |
Formazione di Margaret McLoughlin
| University of California, Irvine | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Canada | 2 |
Posizioni
| Director/Board Member | 5 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 4 |
| Technology Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| QUINCE THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| BIOATLA, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Adapsyn Bioscience, Inc.
Adapsyn Bioscience, Inc. BiotechnologyHealth Technology Adapsyn Bioscience, Inc. operates as a biotechnology company focussed on the discovery and development of novel medicines. The company was founded by Nathan Magarvey and is headquartered in Hamilton, Canada. | Health Technology |
Herophilus, Inc.
Herophilus, Inc. Packaged SoftwareTechnology Services Herophilus, Inc. operates as neurotherapeutics company. It employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. The firm combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. The company was founded by Frederic J. Kerrest, Sean Escola and Saul Kato and is headquartered in San Francisco, CA. | Technology Services |
- Borsa valori
- Insiders
- Margaret McLoughlin
- Esperienza
